D-22 COVID-19 vaccine introduction: Teach to Reach Conference Countdown

More than 2,000 immunization staff have already registered for the Teach to Reach Accelerator Conference hosted by The Geneva Learning Foundation.

Join today's Teach to Reach countdown livestream to learn:

- How this conference can help you get ready for COVID-19 vaccine introduction

- How to secure your seat at the Conference

- How to connect with other Teach to Reach participants from your country and from the global partners

We will also preview preliminary results from the COVID-19 Pulse survey and the Peer Hub's peer learning exercise focused on vaccine hesitancy.

- What we learned about responding vaccine hesitancy from the experience of 700 immunization staff

- What has changed during the pandemic in the last six months – and how immunization staff have adapted

- How frontline health workers can share what they learn – and what difference it makes

- How we can scale up training health workers rapidly and effectively

Join us for a four-part miniseries with the International Vaccine Access Center (IVAC).

In each Live Learning Moment, we will start with a Q&A focused on a specific aspect of serosurveys. Participants will be invited to submit questions in the comments for consideration by the experts from IVAC.

Serosurveys are studies that test body fluids, most commonly blood but also oral fluid, to estimate what proportion of the population has been vaccinated against or previously infected with a pathogen—and how many people remain susceptible.

This series is organized by The Geneva Learning Foundation in collaboration with the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health.

More information: https://www.learning.foundation/serosurveys-event

NOTE START TIME IS 2:15 PM CET, ONE HOUR EARLIER THAN SHOWN

TODAY EPISODE 4 OF 4 IN THIS MINISERIES

IN TODAY’S EPISODE: Alternatives to community-based surveys

Starring: Kyla Hayford and Andrea Carcelan from the International Vaccine Access Center (IVAC)

Join us at this time every day for a four-part miniseries with the International Vaccine Access Center (IVAC), from Tuesday 14 December until Friday 18 December.

In each Live Learning Moment, we will start with a Q&A focused on a specific aspect of serosurveys. Participants will be invited to submit questions in the comments for consideration by the experts from IVAC.

Serosurveys are studies that test body fluids, most commonly blood but also oral fluid, to estimate what proportion of the population has been vaccinated against or previously infected with a pathogen—and how many people remain susceptible.

This series is organized by The Geneva Learning Foundation in collaboration with the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health.

The mini-series will be simultaneously live-streamed on LinkedIn, Facebook, YouTube, and Periscope (Twitter). To ensure that you do not miss this Event, follow these links now to Like, Subscribe, and Share on your preferred platform(s).

TODAY EPISODE 3 OF 4 IN THIS MINISERIES

IN TODAY’S EPISODE: Challenges with community-based serosurveys

Starring: Simon Mutembo and Kyla Hayford from the International Vaccine Access Center (IVAC)

Join us at this time every day for a four-part miniseries with the International Vaccine Access Center (IVAC), from Tuesday 14 December until Friday 18 December.

In each Live Learning Moment, we will start with a Q&A focused on a specific aspect of serosurveys. Participants will be invited to submit questions in the comments for consideration by the experts from IVAC.

Serosurveys are studies that test body fluids, most commonly blood but also oral fluid, to estimate what proportion of the population has been vaccinated against or previously infected with a pathogen—and how many people remain susceptible.

This series is organized by The Geneva Learning Foundation in collaboration with the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health.

The mini-series will be simultaneously live-streamed on LinkedIn, Facebook, YouTube, and Periscope (Twitter). To ensure that you do not miss this Event, follow these links now to Like, Subscribe, and Share on your preferred platform(s).

TODAY EPISODE 2 OF 4 IN THIS MINISERIES

IN TODAY’S EPISODE: How to conduct community-based serosurveys

Starring: Bill Moss and Alvira Hasan from the International Vaccine Access Center (IVAC)

Join us at this time every day for a four-part miniseries with the International Vaccine Access Center (IVAC), from Tuesday 14 December until Friday 18 December.

In each Live Learning Moment, we will start with a Q&A focused on a specific aspect of serosurveys. Participants will be invited to submit questions in the comments for consideration by the experts from IVAC.

Serosurveys are studies that test body fluids, most commonly blood but also oral fluid, to estimate what proportion of the population has been vaccinated against or previously infected with a pathogen—and how many people remain susceptible.

This series is organized by The Geneva Learning Foundation in collaboration with the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health.

The mini-series will be simultaneously live-streamed on LinkedIn, Facebook, YouTube, and Periscope (Twitter). To ensure that you do not miss this Event, follow these links now to Like, Subscribe, and Share on your preferred platform(s).

Join us at this time every day for a four-part miniseries with the International Vaccine Access Center (IVAC), from Tuesday 14 December until Friday 18 December.

In each Live Learning Moment, we will start with a Q&A focused on a specific aspect of serosurveys. Participants will be invited to submit questions in the comments for consideration by the experts from IVAC.

Serosurveys are studies that test body fluids, most commonly blood but also oral fluid, to estimate what proportion of the population has been vaccinated against or previously infected with a pathogen—and how many people remain susceptible.

This series is organized by The Geneva Learning Foundation in collaboration with the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health.

The mini-series will be simultaneously live-streamed on LinkedIn, Facebook, YouTube, and Periscope (Twitter). To ensure that you do not miss this Event, follow these links now to Like, Subscribe, and Share on your preferred platform(s).

More information: https://www.learning.foundation/serosurveys-event

You are invited to a Live Workshop organized by Members of the COVID-19 Peer Hub, a network of more than 6,000 national and sub-national immunization staff from 90 countries.

Prof. Heidi J. Larson is an anthropologist and Director of The Vaccine Confidence Project (VCP) at the London School of Hygiene and Tropical Medicine (LSHTM).

The Vaccine Confidence Project is conducting a global study to track public sentiment and emotions around current and potential measures to contain and treat COVID-19.

Members of the COVID-19 Peer Hub are immunization staff from 90 countries who are likely to be the ones tasked with introducing COVID-19 vaccines.

What do you expect to face with respect to vaccine hesitancy, demand promotion, and community engagement? How are you preparing to face this?

You are invited to a Workshop organized by Members of the COVID-19 Peer Hub, a network of more than 6,000 national and sub-national immunization staff from 90 countries.

Ann Lindstrand heads the Essential Programme on Immunization (EPI) at the World Health Organization.

She will be our guest to listen and learn with national and sub-national immunization staff.

As WHO’s Co-Lead for COVAX, the vaccines pillar of the ACT Accelerator, Ann’s goal is to help end the acute phase of the global pandemic by the end of 2021 by providing access to at least 2 billion doses of safe and effective COVID-19 vaccines to the most vulnerable in all participating economies.

There are now several vaccines for COVID-19 in the pipeline. A vaccine may be reaching your country soon.

Immunization staff, especially those in communities, remain the most trusted advisor and influencer of vaccination decisions.

We are the ones that will need to provide trusted, credible information on the safety and effectiveness of COVID-19 vaccines.

Together, we will explore questions that include:

Have you been involved in new vaccine introduction in the past? What was the most difficult challenge that you faced?

Are you involved in COVID-19 vaccine introduction and roll-out in your country? Do you expect to be involved soon?

Are you involved in developing your country’s National Vaccine Deployment Plan (or at your system level)? What is your role?

What do you think you [in your context] will find the most challenging in order to introduce COVID-19 vaccine?

What do you expect to face with respect to vaccine hesitancy, demand promotion, and community engagement? How are you preparing to face this?

COVID-19 vaccine introduction: Take-aways from a multi-country workshop Susan MacKay from GAVI

Following a private workshop with more than 120 national and sub-national staff from the COVID-19 Peer Hub, specifically focused on vaccine hesitancy and demand promotion, we ask Susan MacKay from GAVI for her reflections and take-aways.

COVID-19 vaccine introduction: Preliminary announcement of the Teach to Reach Conference

Join us today after the General Assembly of the COVID-19 Peer Hub for the preliminary announcement of an event likely to be relevant to all immunization professionals whose countries are going to introduce a vaccine against COVID-19 Peer Hub.

The introduction of COVID-19 vaccines is an unprecedented challenge, with GAVI having declared that 2 billion doses of vaccine will be distributed by the end of 2021.

How do we train and support the massive number of health professionals needed to meet this challenge?

Will the means and methods used in the past be sufficient?

There is an urgent need to find new ways to connect, learn, and lead if we are to beat the pandemic.

Join us today to get a sneak preview of the special event that will bring together vaccination professionals from around the world for three days, starting on 26 January 2021.